Exercise and cardiovascular disease risk in women: interaction with selected endocrine factors.
Read Online

Exercise and cardiovascular disease risk in women: interaction with selected endocrine factors.

  • 647 Want to read
  • ·
  • 74 Currently reading

Published by Vol28(1) in Medicine and Science in Sports and Exercise .
Written in English

Book details:

Edition Notes

Other titlesMedicine and Science in Sports and Exercise.
The Physical Object
Paginationp.p. 3-17
Number of Pages17
ID Numbers
Open LibraryOL20715686M

Download Exercise and cardiovascular disease risk in women: interaction with selected endocrine factors.


Abstract. For a long time it was believed that the endothelium was just an inert layer covering all endovascular surfaces. In the last 40 years, research on endothelium has blossomed and its results have illuminated our comprehension of vessel physiology, blood circulation, and several mechanisms underlying atherosclerosis, hypertension, diabetes, and aging among others.   Introduction. There is strong evidence indicating that cancer survivors may be at an increased risk for developing cardiovascular disease (CVD) (Hooning et al., ; Darby et al., ).This may be as a result of cancer related therapy and changes in lifestyle patterns after diagnosis (Hooning et al., ).Whilst it is well established that exercise reduces CVD risk in Cited by: Exercise is any bodily activity that enhances or maintains physical fitness and overall health and wellness.. It is performed for various reasons, to aid growth and improve strength, preventing aging, developing muscles and the cardiovascular system, honing athletic skills, weight loss or maintenance, improving health and also for enjoyment. Many individuals choose to exercise . Clinical coronary heart disease (CHD) occurred in subjects during eight to nine years of follow-up (average, 8 1/2 years) in a prospective study of to year-old employed men.

PRIMARY CARE The interaction between regular exercise and selected aspects of women's health James F. Clapp III, MD, and Kathleen D. Little, PhD Cleveland. Ohio The public health initiative to increase women's participation in regular recreational exercise to the 90% level raises multiple theoretic concerns about its impact on the reproductive Cited by: Prevention of cardiovascular disease: guidelines for assessment and management of total cardiovascular risk. 1. Cardiovascular diseases prevention and control. 2. Arteriosclerosis prevention and control. 3. Risk factors. 4. Risk assessment. 5. Guidelines. I. World Health Organization. ISBN 92 4 8 (NLM classi cation: WG ). Purpose Cardiovascular disease (CVD) is a leading cause of death among women with nonmetastatic breast cancer. Whether exercise is associated with reductions in CVD risk in patients with breast cancer with an elevated CVD risk phenotype is not known. Methods Using a prospective design, women (n = 2,; mean age, 57 years) diagnosed with nonmetastatic Cited by:   A major cause of cardiovascular morbidity and mortality, diabetes increases the risk of developing coronary heart disease (CHD) by three- to sevenfold in women and by two- to threefold in men. The economic costs of diabetes and cardiovascular disease (CVD) in this country have been estimated at $ billion (34) and $ billion (73 Cited by:

Menopause, also known as the climacteric, is the time in most women's lives when menstrual periods stop permanently, and they are no longer able to bear children. Menopause typically occurs between 49 and 52 years of age. Medical professionals often define menopause as having occurred when a woman has not had any menstrual bleeding for a year. It may also be defined Specialty: Gynecology.   An interaction effect was observed for six minute walk test (% [–] ES , p ≤ ) with the LVHIIT group demonstrating greater improvements. Conclusion These preliminary findings suggest that both interventions can induce improvements in quality of life, functional capacity and selected cardiovascular disease risk by: Cardiovascular risk factors and birth weight The population characteristics are summarized in Table 1. The number and percentage of small, medium and large women taking hypoglycaemic agents was 18/ (%), 11/ (%) and 0/74 (0%) (P Cited by: 6. Background and Objectives: Data emerging from the Women’s Health Initiative (WHI) study point toward an association between menopausal hormone therapy (MHT) and cardiovascular (CV) risk. However, post hoc subgroup analyses stratifying participants according to their age and time since menopause, have opened the way to a better understanding of the relationship between Author: Paola Villa, Inbal Dona Amar, Maayan Shachor, Clelia Cipolla, Fabio Ingravalle, Giovanni Scambia.